Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Atsuta, Yoshiko"" wg kryterium: Autor


Tytuł :
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.
Autorzy :
Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi, 466-8560, Japan. .
Kuwatsuka Y; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Sugita J; Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Takahashi S; Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Ozeki K; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan.
Yoshioka S; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Nakamae H; Department of Hematology, Osaka City University Hospital, Osaka, Japan.
Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Morishige S; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan.
Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Katsuoka Y; Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
Kouzai Y; Department of Transfusion Medicine, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Fukuda T; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
Teshima T; Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Jun; Vol. 113 (6), pp. 840-850. Date of Electronic Publication: 2021 Feb 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Autorzy :
Akahoshi Y; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, 330-8503, Japan.
Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nishiwaki S; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Mizuta S; Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.
Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, 330-8503, Japan.; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Sakai H; Department of Hematology, Shinshu University, Matsumoto, Japan.
Takada S; Department of Hematology, Saiseikai Maebashi Hospital, Maebashi, Japan.
Fukuda T; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
Ashida T; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Osakasayama, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama city, Saitama, 330-8503, Japan. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Jun; Vol. 113 (6), pp. 832-839. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
Autorzy :
Yokoyama H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan. .
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kawahara Y; Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Takahashi S; Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Noguchi Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Katsuoka Y; Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Ohta T; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
Kanda Y; Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1352-1363. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
Autorzy :
Sakurai M; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. .
Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Kanaya M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Shiratori S; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Wakayama T; Department of Hematology and Oncology, Shimane Prefectural Central Hospital, Izumo, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
Kubo K; Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
Amano I; Department of Respiratory Medicine and Hematology, Nara Medical University Hospital, Nara, Japan.
Ohta T; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Miyazaki Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kondo E; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
Pokaż więcej
Corporate Authors :
Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1462-1466. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
Autorzy :
Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. .
Hara M; Center for Community-Based Healthcare Research and Education, Shimane University, Shimane, Japan.
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Itonaga H; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Aoki J; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Kato J; Division of Hematology and department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Onishi Y; Department of Hematology, Tohoku University Hospital, Miyagi, Japan.
Takahashi S; Division of Molecular Therapy, the Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Nakamae H; Department of Hematology, Graduate School of Medicine Osaka City University, Osaka, Japan.
Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Ishiyama K; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 May 15. Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
Autorzy :
Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan. .
Usui Y; Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Aichi, Japan.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan.; Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Aichi, Japan.
Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Yoshida S; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
Kondo T; Department of Hematology and Oncology, Kyoto University, Kyoto, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Kato S; Department of Innovative Medical Science, Tokai University School of Medicine, Kanagawa, Japan.
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Kimura F; Division of Hematology, National Defense Medical College, Tokorozawa, Japan.
Kanda Y; Division of Hematology, Jichi Medical University, Tochigi, Japan.
Miyamura K; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Kanda J; Department of Hematology and Oncology, Kyoto University, Kyoto, Japan.
Pokaż więcej
Corporate Authors :
JSHCT Donor Source Working Group
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 May 14. Date of Electronic Publication: 2021 May 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pretransplantation Red Blood Cell and Platelet Transfusion Burden in De Novo Myelodysplastic Syndrome Undergoing Allogeneic Transplantation.
Autorzy :
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: .
Aoki J; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
Ohta T; Department of Hematology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Onishi Y; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Corporate Authors :
Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 May 12. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study.
Autorzy :
Kurosawa S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kaito S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Hasegawa Y; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan.
Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Aichi, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 May 12, pp. 1-7. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
Autorzy :
Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. .
Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Miyamoto T; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan.
Hashii Y; Department of Cancer Immunotherapy/Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Teshima T; Department of Hematology, Hokkaido University Graduate School of Medical Science, Sapporo, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 May 11. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
Autorzy :
Shiratori S; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Sugita J; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Fuji S; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Aoki J; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Hashimoto D; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ashida T; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital, Osakasayama, Japan.
Ueda Y; Department of Hematology/Oncology and Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Sawayama Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan. .; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 May 07. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Autorzy :
Bernard E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Devlin SM; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tuechler H; Vienna, Austria.
Medina-Martinez JS; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yoshizato T; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Shiozawa Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Saiki R; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
Levine MF; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Arango JE; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Zhou Y; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Solé F; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona, Spain.
Cargo CA; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
Haase D; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
Creignou M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.
Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gundem G; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sarian A; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
van de Loosdrecht AA; Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, the Netherlands.
Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Tobiasson M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Kosmider O; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris, France.
Follo MY; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School, Hannover, Germany.
Pinheiro RF; Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil.
Santini V; MDS Unit, Hematology, AOU Careggi, University of Florence, Florence, Italy.
Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
Boultwood J; Radcliffe Department of Medicine, University of Oxford and Oxford BRC Haematology Theme, Oxford, UK.
Santos FPS; Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Schanz J; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Tsurumi H; Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan.
Takaori-Kondo A; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kiguchi T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan.
Polprasert C; Department of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Bennett JM; Lab. Medicine and Pathology, Hematology/Oncology, University of Rochester Medical Center, Rochester, NY, USA.
Klimek VM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Belickova M; Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
Palomo L; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona, Spain.
Sanz G; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Ades L; Department of Hematology, Hôpital St Louis and Paris University, Paris, France.
Della Porta MG; Humanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Elias HK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Smith AG; Department of Health Sciences, University of York, York, UK.
Werner Y; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Patel M; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Viale A; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Vanness K; Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Neuberg DS; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
Stevenson KE; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
Menghrajani K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bolton KL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Fenaux P; Department of Hematology, Hôpital St Louis and Paris University, Paris, France.
Pellagatti A; Radcliffe Department of Medicine, University of Oxford and Oxford BRC Haematology Theme, Oxford, UK.
Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany.
Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School, Hannover, Germany.
Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Finelli C; Institute of Hematology, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Voso MT; MDS Cooperative Group GROM-L, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
Shih LY; Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan City, Taiwan.
Fontenay M; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris, France.
Jansen JH; Laboratory Hematology, Department LABGK, Radboud University Medical Centre, Nijmegen, the Netherlands.
Cervera J; Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.
Ebert BL; Department of Medical Oncology and Howard Hughes Medical Institute, Dana-Farber Cancer Center, Boston, MA, USA.
Bejar R; UC San Diego Moores Cancer Center, La Jolla, CA, USA.
Greenberg PL; Stanford University Cancer Institute, Stanford, CA, USA.
Cazzola M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Papaemmanuil E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 May; Vol. 27 (5), pp. 927.
Typ publikacji :
Published Erratum
Tytuł :
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Autorzy :
Yamauchi N; Department of Hematology, National Cancer Center East Hospital, Kashiwa, Japan.
Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Sakai R; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Miyashita K; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
Moriuchi Y; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
Tsujimura H; Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
Kubota N; Department of Hematology, Saitama Cancer Center, Saitama, Japan.
Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Igarashi T; Department of Hematology, Gunma Prefectural Cancer Center, Gunma, Japan.
Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Yoshida S; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Ohmura, Japan.
Kojima K; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Inoue Y; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Tsukamoto N; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
Ohtsuka E; Department of Hematology, Oita prefectural Hospital, Oita, Japan.
Suzuki S; Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
Inaguma Y; Division of Hematology, Fujita Health University, Toyoake, Japan.
Ichikawa S; Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Gomyo H; Division of Hematology, Hyogo Cancer Center, Akashi, Japan.
Ushijima Y; Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nosaka K; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan.
Kurata M; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Tanaka Y; Department of Virology and Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ueda R; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute, Japan.
Mizokami M; Genome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa, Japan.
Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 May; Vol. 112 (5), pp. 1943-1954. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Antiviral Agents/*therapeutic use
Hepatitis B/*drug therapy
Hepatitis B Surface Antigens/*blood
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Rituximab/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Alanine Transaminase/blood ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Case-Control Studies ; Cyclophosphamide/administration & dosage ; DNA, Viral/blood ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Female ; Hepatitis B/blood ; Hepatitis B/epidemiology ; Hepatitis B virus/genetics ; Humans ; Incidence ; Induction Chemotherapy/methods ; Japan/epidemiology ; Liver Function Tests ; Lymphoma, Large B-Cell, Diffuse/blood ; Lymphoma, Large B-Cell, Diffuse/immunology ; Lymphoma, Large B-Cell, Diffuse/virology ; Male ; Middle Aged ; Prednisone/administration & dosage ; Retrospective Studies ; Rituximab/administration & dosage ; Survival Analysis ; Vincristine/administration & dosage ; Virus Activation
Czasopismo naukowe
Tytuł :
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes.
Autorzy :
Yanada M; Aichi Cancer Center, Nagoya, Japan. .
Konuma T; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yamasaki S; National Hospital Organization Kyusyu Medical Center, Fukuoka, Japan.
Kondo T; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Fukuda T; National Cancer Center Hospital, Tokyo, Japan.
Shingai N; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Sawa M; Anjo Kosei Hospital, Anjo, Japan.
Ozawa Y; Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Tanaka M; Kanagawa Cancer Center, Yokohama, Japan.
Uchida N; Toranomon Hospital, Tokyo, Japan.
Nakamae H; Graduate School of Medicine, Osaka City University, Osaka, Japan.
Katayama Y; Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
Matsuoka KI; Okayama University Hospital, Okayama, Japan.
Kimura T; Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Kanda Y; Jichi Medical University, Shimotsuke, Japan.
Ichinohe T; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yano S; The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 May; Vol. 56 (5), pp. 1126-1133. Date of Electronic Publication: 2020 Dec 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
Autorzy :
Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan. .
Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Fuji S; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Yakushijin K; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Ikegame K; Department of Hematology, Hyogo College of Medicine Hospital, Nishinomiya, Japan.
Yano S; Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
Shingai N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Onishi Y; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Apr 29. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
Autorzy :
Saito Y; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan. .; Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo, Japan. .
Urashima M; Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo, Japan.
Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ogawa A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
Kiyotani C; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Yuza Y; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Watanabe K; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
Kosaka Y; Department of Hematology and Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Kikuta A; Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan.
Okada K; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
Koga Y; Department of Pediatrics, Kyushu University Hospital, Fukuoka, Japan.
Fujimura J; Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
Atsuta Y; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Matsumoto K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Apr 28. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
Autorzy :
Inoue Y; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan. .; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan. .
Okinaka K; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Fuji S; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Inamoto Y; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Iwato K; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ogata M; Department of Hematology, Oita University Hospital, Oita, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
Transplant Complications Working Group of The Japan Society for Hematopoietic Cell Transplantation
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2021 Apr 19. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia.
Autorzy :
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan. Electronic address: .
Takami A; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Kawamura K; Department of Hematology, Tottori University Hospital, Yonago, Japan.
Arai Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
Kondo T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
Kawata T; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yoshida S; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Kanda Y; Division of Hematology, Jichi Medical University, Simotsuke, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Apr; Vol. 27 (4), pp. 314.e1-314.e10. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Autorzy :
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: .
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yamasaki S; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Shimomura Y; Department of Hematology, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.
Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Nakamae H; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Morishige S; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Kanda Y; Division of Hematology, Jichi Medical University, Tochigi, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Apr; Vol. 27 (4), pp. 334.e1-334.e11. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
Autorzy :
Soejima T; Department of Family Nursing, School of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .; Department of Health Quality and Outcome Research, Division of Nursing Systems, Global Nursing Research Center, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. .
Shiohara M; Department of Pediatrics, Matsumoto Dental University Hospital, Shiojiri, Japan.
Ishida Y; Pediatric Medical Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Hayakawa A; Department of Palliative Care, Yodogawa Christian Hospital, Osaka, Japan.
Sato A; Department of Hematology/Oncology, Miyagi Children's Hospital, Sendai, Japan.
Kamibeppu K; Department of Family Nursing, School of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.; Department of Health Quality and Outcome Research, Division of Nursing Systems, Global Nursing Research Center, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yamashita T; Department of Hematology/Oncology, St. Luke's International Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Apr; Vol. 113 (4), pp. 566-575. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.
Autorzy :
Isobe M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan.
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. .
Masuko M; Department of Hematopoietic Cell Transplantation, Niigata University Medical and Dental Hospital, Niigata, Japan.
Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Miyakoshi S; Department of Hematology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Sugio Y; Department of Internal Medicine, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Yoshida S; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Matsuhashi Y; Department of Hematology, Kawasaki Medical School Hospital, Kurashiki, Japan.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Aotsuka N; Division of Hematology-Oncology, Japanese Red Cross Society Narita Hospital, Narita, Japan.
Kouzai Y; Department of Transfusion Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Pokaż więcej
Corporate Authors :
Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
Źródło :
Annals of hematology [Ann Hematol] 2021 Jul; Vol. 100 (7), pp. 1849-1861. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies